DFS is an important endpoint in clinical trials because it helps to determine the effectiveness of new treatments. A longer DFS indicates that the treatment is effective at controlling the disease and preventing recurrence. This measure is particularly useful in comparing different treatment modalities and in making decisions about the best course of action for future patients.
